A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation

Calcineurin inhibitor (CNI) therapy after lung transplantation increases risk of kidney failure. Early everolimus‐based quadruple low CNI immunosuppression may improve renal function without compromising efficacy or safety. A prospective, randomized, open‐label, 12‐month multicenter trial was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottlieb, Jens, Neurohr, Claus, Müller‐Quernheim, Joachim, Wirtz, Hubert, Sill, Bjoern, Wilkens, Heinrike, Bessa, Vasiliki, Knosalla, Christoph, Porstner, Martina, Capusan, Carmen, Strüber, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590654/
https://www.ncbi.nlm.nih.gov/pubmed/30615259
http://dx.doi.org/10.1111/ajt.15251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590654/
https://www.ncbi.nlm.nih.gov/pubmed/30615259
http://dx.doi.org/10.1111/ajt.15251

Ejemplares similares